SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-20-022641
Filing Date
2020-02-03
Accepted
2020-02-03 12:42:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d848899dsc13g.htm SC 13G 33413
  Complete submission text file 0001193125-20-022641.txt   34835
Mailing Address P.O. BOX 150183 AUSTIN TX 78715
Business Address P.O. BOX 150183 AUSTIN TX 78715 512-809-8549
Lung Therapeutics, Inc. (Filed by) CIK: 0001611241 (see all company filings)

IRS No.: 461383209 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Subject) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91311 | Film No.: 20567802
SIC: 2834 Pharmaceutical Preparations